Serum FGF-23 increases very early in the course of CKD, long before the development of hyperphosphatemia; thus, a high FGF-23 concentration is the most sensitive and earliest marker of disordered phosphorus metabolism in CKD [19]. This evidence concerns the gene FGF23 and chronic kidney disease.